Long-term immunity and protection against SARS-CoV-2 XBB.1.5 following homologous and heterologous mRNA and MVA vaccination.
- DOI
- 10.3389/fimmu.2026.1916109
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1916109,
title = {Long-term immunity and protection against SARS-CoV-2 XBB.1.5 following homologous and heterologous mRNA and MVA vaccination.},
author = {Pérez P and Esteso G and García-García I and Flores S and Sánchez-Corzo C and Noriega MA and Casasnovas JM and Esteban M and García-Arriaza J},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1916109},
url = {https://doi.org/10.3389/fimmu.2026.1916109}
}RIS
TY - JOUR TI - Long-term immunity and protection against SARS-CoV-2 XBB.1.5 following homologous and heterologous mRNA and MVA vaccination. AU - Pérez P AU - Esteso G AU - García-García I AU - Flores S AU - Sánchez-Corzo C AU - Noriega MA AU - Casasnovas JM AU - Esteban M AU - García-Arriaza J PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1916109 UR - https://doi.org/10.3389/fimmu.2026.1916109 ER -
APA
P, P., G, E., I, G., S, F., C, S., MA, N., JM, C., M, E., & J, G. (2026). Long-term immunity and protection against SARS-CoV-2 XBB.1.5 following homologous and heterologous mRNA and MVA vaccination.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1916109
Source records
- pubmed · retrieved 2026-09-26T02:41:27.643Z